Skip to main content
. 2023 Jun 1;27(6):339–347. doi: 10.14744/AnatolJCardiol.2023.2825

Table 1.

Cardiac and ECG Measurements of Animals According to Study Groups

Controla DAPAb DOXc DAPA + DOXd P groups P measures
First weight measurement, g 272.00 ± 36.72 299.60 ± 16.95 287.90 ± 17.51 287.10 ± 17.40 <.001*
a–c
a–d
<.001*
Second weight measurement, g 301.40 ± 42.25 301.50 ± 15.23 273.40 ± 18.31 242.10 ± 21.08
Third weight measurement, g 338.20 ± 43.37 325.00 ± 21.53 280.00 ± 21.00 265.33 ± 23.21
Fourth weight measurement, g 338.10 ± 41.49 325.00 ± 22.45 275.50 ± 24.22 275.88 ± 21.24
Ejection fraction, baseline, % 79.30 ± 2.40 79.10 ± 2.23 78.50 ± 2.46 78.00 ± 3.01 <.001*
a–c
<.001*
Ejection fraction, week 6, % 78.80 ± 2.57 80.90 ± 3.10 66.00 ± 9.98 74.00 ± 4.03
Fractional shortening baseline, % 47.20 ± 3.88 47.20 ± 4.51 49.30 ± 5.20 46.70 ± 4.49 .764 <.001*
Fractional shortening week 6, % 48.10 ± 4.40 47.40 ± 4.76 43.20 ± 4.73 44.33 ± 3.80
End-diastolic volume baseline, μL 275.70 ± 12.18 271.90 ± 15.83 269.20 ± 12.73 278.80 ± 22.92 .141 <.001*
End-diastolic volume week 6, μL 277.50 ± 11.22a 269.65 ± 15.53b 307.70 ± 35.32a.b 284.11 ± 16.91
End-systolic volume baseline, μL 57.50 ± 10.42 65.90 ± 7.63 55.00 ± 7.36a 66.30 ± 11.64a .205 <.001*
End-systolic volume week 6, μL 59.10 ± 10.25 65.20 ± 8.09 68.70 ± 11.64 68.77 ± 10.38
Heart rate baseline, bpm 331.30 ± 24.09 352.60 ± 28.96 358.10 ± 19.30 345.90 ± 28.51 .026*
a–c
.014
Heart rate week 6, bpm 331.70 ± 24.77a 354.40 ± 25.25 378.90 ± 42.82a 348.33 ± 25.42
QTc baseline, ms 171.40 ± 19.96 169.80 ± 17.11 170.90 ± 18.71 171.30 ± 17.99 .525 <.001*
QTc week 6, ms 171.80 ± 19.67 169.20 ± 14.92 192.30 ± 28.91 174.77 ± 16.72
QRS baseline, ms 14.70 ± 2.21 14.90 ± 2.23 14.80 ± 2.74 15.00 ± 2.10 .001*
a–c
<.001*
QRS week 6, ms 14.90 ± 2.23a 14.70 ± 2.11b 23.10 ± 4.38a.b.c 15.77 ± 1.92c

Data are given as mean ± SD.

*Significant at the .05 level according to two-way repeated measure ANOVA.

a,b,c,dThe letters denote the significant pairwise study groups according to Dunnet t (2-sided) post-hoc test.

bpm, beat per minute; DAPA, dapagliflozin; DOX, doxorubicin; QTc, corrected QT interval.